1. Home
  2. GERN vs UTF Comparison

GERN vs UTF Comparison

Compare GERN & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.37

Market Cap

753.3M

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Infrastructure Fund Inc

UTF

Cohen & Steers Infrastructure Fund Inc

HOLD

Current Price

$23.89

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GERN
UTF
Founded
1990
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
753.3M
2.4B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
GERN
UTF
Price
$1.37
$23.89
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
6.8M
171.7K
Earning Date
02-25-2026
01-01-0001
Dividend Yield
N/A
7.19%
EPS Growth
N/A
N/A
EPS
N/A
2.84
Revenue
$183,403,000.00
$138,636,669.00
Revenue This Year
$147.42
N/A
Revenue Next Year
$39.42
N/A
P/E Ratio
N/A
$9.16
Revenue Growth
522.13
19.80
52 Week Low
$1.04
$22.05
52 Week High
$3.59
$26.53

Technical Indicators

Market Signals
Indicator
GERN
UTF
Relative Strength Index (RSI) 57.05 46.96
Support Level $1.30 $24.13
Resistance Level $1.37 $24.48
Average True Range (ATR) 0.06 0.28
MACD -0.01 0.02
Stochastic Oscillator 43.33 44.44

Price Performance

Historical Comparison
GERN
UTF

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.

Share on Social Networks: